EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Canagliflozin Inhibits Palmitic Acid-Induced Vascular Cell Aging In Vitro through ROS/ERK and Ferroptosis Pathways

Fang Wan, Xin He, Weidong Xie iD

Antioxidants · 11.07.2024 · 13 (7) · 831

DOI: 10.3390/antiox13070831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 11.07.2024. Verfasst von Fang Wan und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Key R&D Program of China, Sustainable Development Special Project of Shenzhen Science and Technology Innovation Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular aging is one of the reasons for the high incidence of cardiovascular diseases nowadays, as vascular cells age due to various internal and external factors. Among them, high fat is an important inducer. Canagliflozin (CAN) is one of the SGLT2 inhibitors that has been shown to have cardiovascular protective effects in addition to lowering blood sugar, but the specific mechanism is not clear. This study first established a vascular aging model using palmitic acid (PA), then tested the effect of CAN on PA-induced vascular aging, and finally examined the mechanism of CAN’s anti-vascular aging via ROS/ERK and ferroptosis pathways. We found that CAN alleviates PA-induced vascular cell aging by inhibiting the activation of ROS/ERK and ferroptosis signaling pathways. This study reveals new mechanisms of lipid-induced vascular aging and CAN inhibition of vascular aging from the perspectives of ROS/ERK and ferroptosis pathways, which is expected to provide new ideas for the development of related drugs in the future.

Schlagwörter

Stichwörter der Autor:innen

ROS/ERKcanagliflozinferroptosissenescence

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
  • Shenzhen Key Laboratory of Health Science and Technology, Institute of Biopharmaceutical and Health, Tsinghua University, Shenzhen 518055, China.
  • Open FIESTA Center, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.

ORCID-Profile: Weidong Xie

Förderung

  • National Key R&D Program of China
  • National Key R&D Program of China
  • Sustainable Development Special Project of Shenzhen Science and Technology Innovation Committee

Zitieren

APA

Wan, F., He, X., & Xie, W. (2024). Canagliflozin Inhibits Palmitic Acid-Induced Vascular Cell Aging In Vitro through ROS/ERK and Ferroptosis Pathways. Antioxidants, 13(7), 831. https://doi.org/10.3390/antiox13070831

Vancouver

Wan F, He X, Xie W. Canagliflozin Inhibits Palmitic Acid-Induced Vascular Cell Aging In Vitro through ROS/ERK and Ferroptosis Pathways. Antioxidants. 2024;13(7):831. doi:10.3390/antiox13070831

BibTeX
@article{Wan2024,
  author = {Wan, Fang and He, Xin and Xie, Weidong},
  title = {Canagliflozin Inhibits Palmitic Acid-Induced Vascular Cell Aging In Vitro through ROS/ERK and Ferroptosis Pathways},
  journal = {Antioxidants},
  year = {2024},
  volume = {13},
  number = {7},
  pages = {831},
  doi = {10.3390/antiox13070831}
}
Kostenlos starten →